Pacira BioSciences, Inc. PCRX Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s long-term debt?
- Pacira BioSciences, Inc. (PCRX) reported long-term debt of $367.66M in Q1 2026.
- How has Pacira BioSciences, Inc.'s long-term debt changed year-over-year?
- Pacira BioSciences, Inc.'s long-term debt increased by 262.3% year-over-year, from $101.49M to $367.66M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.